CoChat

Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4

Open access
Bumbaca, Daniela, Wong, Anne, Drake, Elizabeth, Reyes II, Arthur E., Lin, Benjamin C., Stephan, Jean-Philippe, Desnoyers, Luc, Shen, Ben-Quan, Dennis, Mark S. · 2011 · mAbs
Cited by 105

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Off-target binding can significantly affect the pharmacokinetics (PK), tissue distribution, efficacy and toxicity of a therapeutic antibody. Herein we describe the development of a humanized anti- fibroblast growth factor receptor 4 (FGFR4) antibody as a potential therapeutic for hepatocellular carcinoma (HCC). A chimeric anti FGFR4 monoclonal antibody (chLD1) was previously shown to block ligand binding and to inhibit FGFR4 mediated signaling as well as tumor growth in vivo. A humanized version of chLD1, hLD1.vB, had similar binding affinity and in vitro blocking activity, but it exhibited rapid clearance, poor target tissue biodistribution and limited efficacy when compared to chLD1 in a HUH7 human HCC xenograft mouse model. These problems were traced to instability of the molecule in rodent serum. Size exclusion high performance liquid chromatography, immunoprecipitation and mass spectral sequencing identified a specific interaction between hLD1.vB and mouse complement component 3 (C3). A PK study in C3 knock-out mice further confirmed this specific interaction. Subsequently, an affinity-matured variant derived from hLD1.vB (hLD1.v22), specifically selected for its lack of binding to mouse C3 was demonstrated to have a PK profile and in vivo efficacy similar to that of chLD1 in mice. Although reports of non-specific off-target binding have been observed for other antibodies, this represents the first report identifying a specific off-target interaction that affected disposition and biological activity. Screens developed to identify general non-specific interactions are likely to miss the rare and highly specific cross-reactivity identified in this study, thus highlighting the importance of animal models as a proxy for avoiding unexpected clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/mabs.3.4.15786

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Test of a Statistical Model for Molecular Recognition in Biological Repertoires

    ROSENWALD, S., KAFRI, R., & LANCET, D. (2002) · Journal of Theoretical Biology · doi:10.1006/jtbi.2002.2538 · Cited by 37 · cited 1×

    “The likelihood of identifying an off-target binding event is a function of the size of the protein repertoire and the affinity that is considered relevant.(11) Given the huge complexity of an in vivo system and the typically high therapeutic dosing in a clinical setting, the odds of an off-target event that affects ef…”
    Background

Show all 1 references

Cited by

See all 105

Metadata

Authors
Bumbaca, D., Wong, A., Drake, E., Reyes II, A. E., Lin, B. C., Stephan, J.-P., Desnoyers, L., Shen, B.-Q., & Dennis, M. S.
Venue
mAbs
Published
2011-07
Volume
3
Issue
4
Pages
376-386
ISSN
  • 1942-0862 (ISSN-L)
  • 1942-0870
OpenAlex
W2035742026
Cited by
105
References
1
FWCI
5.29
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4. https://app.cochat.ai/papers/10.4161/mabs.3.4.15786
The paper
Bumbaca, D., Wong, A., Drake, E., Reyes II, A. E., Lin, B. C., Stephan, J.-P., Desnoyers, L., Shen, B.-Q., & Dennis, M. S. (2011). Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4. mAbs. https://doi.org/10.4161/mabs.3.4.15786

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.